|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
The role of CT scan of the chest in Pre-anesthetic assessment of the severity of COVID-19 and the correlations between CT measurements of the aortic and pulmonary arteries diameters and severity of pneumonia.
Description: The pneumonia severity will be assessed by the radiologist.Measure: pneumonia severity. Time: 90 days
Description: Aorta cross sectional diameter will be calculated by using cursor method on CT scanMeasure: Aorta diameter Time: 90 days
Description: Pulmonary artery sectional diameter will be calculated by using cursor method on CT scanMeasure: Pulmonary artery diameter Time: 90 days
Description: Pulmonary artery diameter TO Aorta diameter ratio will be calculatedMeasure: Pulmonary artery diameter TO Aorta diameter ratio Time: 90 days
Description: The parenchymal lesions will be described by the radiologistMeasure: Description of the lesions found in the CT scan Time: 90 days
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports